Page 53 - Read Online

Page 16 of 16 Chandrasekar et al. Mini-invasive Surg 2021;5:33 https://dx.doi.org/10.20517/2574-1225.2021.12

79. Aghaie Meybodi M, Shakoor D, Nanavati J, et al. Unilateral versus bilateral endoscopic stenting in patients with unresectable
malignant hilar obstruction: a systematic review and meta-analysis. Endosc Int Open 2020;8:E281-90. DOI PubMed PMC
80. Dolak W, Schreiber F, Schwaighofer H, et al; Austrian Biliary RFA Study Group. Endoscopic radiofrequency ablation for malignant
biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc 2014;28:854-60. DOI PubMed
81. Sofi AA, Khan MA, Das A, et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for
malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc 2018;87:944-51.e1. DOI PubMed
82. Ortner MA. Photodynamic therapy for cholangiocarcinoma. Lasers Surg Med 2011;43:776-80. DOI PubMed
83. Cheon YK, Cho YD, Baek SH, et al. Comparison of survival of advanced hilar cholangiocarcinoma after biliary drainage alone versus
photodynamic therapy with external drainage. Korean J Gastroenterol 2004;44:280-7. PubMed
84. Ortner ME, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective
study. Gastroenterology 2003;125:1355-63. DOI PubMed
85. Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after
photodynamic therapy. Am J Gastroenterol 2005;100:2426-30. DOI PubMed
86. Wiedmann M, Berr F, Schiefke I, et al. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-
up of a prospective phase II study. Gastrointest Endosc 2004;60:68-75. DOI PubMed
87. Prasad GA, Wang KK, Baron TH, et al. Factors associated with increased survival after photodynamic therapy for
cholangiocarcinoma. Clin Gastroenterol Hepatol 2007;5:743-8. DOI PubMed
88. Cheon YK, Lee TY, Lee SM, Yoon JY, Shim CS. Longterm outcome of photodynamic therapy compared with biliary stenting alone in
patients with advanced hilar cholangiocarcinoma. HPB (Oxford) 2012;14:185-93. DOI PubMed PMC
89. Giovannini M. EUS-guided hepaticogastrostomy. Endosc Ultrasound 2019;8:S35-9. DOI PubMed PMC
90. Artifon EL, Perez-Miranda M. EUS-guided choledochoduodenostomy for malignant distal biliary obstruction palliation: an article
review. Endosc Ultrasound 2012;1:2-7. DOI PubMed PMC
91. Baars JE, Kaffes AJ, Saxena P. EUS-guided biliary drainage: a comprehensive review of the literature. Endosc Ultrasound 2018;7:4-9.
DOI PubMed PMC
92. Minaga K, Ogura T, Shiomi H, et al. Comparison of the efficacy and safety of endoscopic ultrasound-guided
choledochoduodenostomy and hepaticogastrostomy for malignant distal biliary obstruction: multicenter, randomized, clinical trial. Dig
Endosc 2019;31:575-82. DOI PubMed
93. Uemura RS, Khan MA, Otoch JP, Kahaleh M, Montero EF, Artifon ELA. EUS-guided choledochoduodenostomy versus
hepaticogastrostomy: a systematic review and meta-analysis. J Clin Gastroenterol 2018;52:123-30. DOI PubMed
94. Moole H, Bechtold ML, Forcione D, Puli SR. A meta-analysis and systematic review: success of endoscopic ultrasound guided biliary
stenting in patients with inoperable malignant biliary strictures and a failed ERCP. Medicine (Baltimore) 2017;96:e5154. DOI
PubMed PMC